Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Seagen stock | 177.19

Own Seagen stock in just a few minutes.

Fact checked

Seagen Inc is a biotechnology business based in the US. Seagen shares (SGEN) are listed on the NASDAQ and all prices are listed in US Dollars. Seagen employs 1,605 staff and has a trailing 12-month revenue of around USD$1 billion.

How to buy shares in Seagen

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Seagen. Find the stock by name or ticker symbol: SGEN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Seagen reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$177.19, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Seagen, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Seagen. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Seagen's share price?

Since the stock market crash in March caused by coronavirus, Seagen's share price has had significant positive movement.

Its last market close was USD$177.19, which is 33.97% up on its pre-crash value of USD$117 and 95.64% up on the lowest point reached during the March crash when the shares fell as low as USD$90.57.

If you had bought USD$1,000 worth of Seagen shares at the start of February 2020, those shares would have been worth USD$913.28 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,630.15.

Seagen share price

Use our graph to track the performance of SGEN stocks over time.

Seagen shares at a glance

Information last updated 2020-10-18.
Latest market close USD$177.19
52-week range USD$90.57 - USD$213.94
50-day moving average USD$180.7412
200-day moving average USD$162.1427
Wall St. target price USD$193.44
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.744

Buy Seagen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Seagen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Seagen price performance over time

Historical closes compared with the close of $177.19 from 2020-11-16

1 week (2020-11-20) N/A
1 month (2020-10-30) 6.23%
3 months (2020-08-28) N/A
6 months (2020-05-28) N/A
1 year (2019-11-27) N/A
2 years (2018-11-27) N/A
3 years (2017-11-27) N/A
5 years (2015-11-27) N/A

Seagen financials

Revenue TTM USD$1 billion
Gross profit TTM USD$153.4 million
Return on assets TTM -11.2%
Return on equity TTM -16.57%
Profit margin -25.18%
Book value $10.434
Market capitalisation USD$35 billion

TTM: trailing 12 months

Shorting Seagen shares

There are currently 4.4 million Seagen shares held short by investors – that's known as Seagen's "short interest". This figure is 7.8% up from 4.0 million last month.

There are a few different ways that this level of interest in shorting Seagen shares can be evaluated.

Seagen's "short interest ratio" (SIR)

Seagen's "short interest ratio" (SIR) is the quantity of Seagen shares currently shorted divided by the average quantity of Seagen shares traded daily (recently around 1.2 million). Seagen's SIR currently stands at 3.61. In other words for every 100,000 Seagen shares traded daily on the market, roughly 3610 shares are currently held short.

However Seagen's short interest can also be evaluated against the total number of Seagen shares, or, against the total number of tradable Seagen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Seagen's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Seagen shares in existence, roughly 30 shares are currently held short) or 0.0787% of the tradable shares (for every 100,000 tradable Seagen shares, roughly 79 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Seagen.

Find out more about how you can short Seagen stock.

Seagen's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Seagen.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Seagen's total ESG risk score

Total ESG risk: 29.88

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Seagen's overall score of 29.88 (as at 10/01/2020) is nothing to write home about – landing it in it in the 56th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Seagen is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Seagen's environmental score

Environmental score: 1.18/100

Seagen's environmental score of 1.18 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seagen is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Seagen's social score

Social score: 23.34/100

Seagen's social score of 23.34 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seagen is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Seagen's governance score

Governance score: 10.36/100

Seagen's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Seagen is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

Seagen Inc was last rated for ESG on: 2020-10-01.

Total ESG score 29.88
Total ESG percentile 55.9
Environmental score 1.18
Environmental score percentile 5
Social score 23.34
Social score percentile 5
Governance score 10.36
Governance score percentile 5

Seagen share dividends

We're not expecting Seagen to pay a dividend over the next 12 months.

Seagen share price volatility

Over the last 12 months, Seagen's shares have ranged in value from as little as $90.57 up to $213.94. A popular way to gauge a stock's volatility is its "beta".

SGEN.US volatility(beta: 1.13)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Seagen's is 1.1274. This would suggest that Seagen's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Seagen overview

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; and PADCEV, an ADC composed of an anti-Nectin-4 monoclonal antibody for the treatment of metastatic urothelial cancers. It also develops Tucatinib, an investigational oral, small molecule TKI for HER2, a growth factor receptor; and Tisotumab Vedotin, an ADC composed of a human antibody that binds to tissue factor to treat various solid tumors, including cervical, ovarian, prostate, and bladder. In addition, the company develops ladiratuzumab vedotin, an ADC targeting LIV-1 and metastatic triple-negative breast cancer; SEA-BCMA, a clinical-stage non-fucosylated BCMA-directed antibody for patients with relapsed or refractory multiple myeloma. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; biotechnology and pharmaceutical companies; and Merck. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site